Deletion and inhibition of OPA1 also causes mitochondrial dysfunction, increased levels of IL6, IL1, ROS, mitochondrial DNA damage, and subsequent stimulation of transcription factors such as FoxO3 and NF-κB which are associated with sarcopenia and premature death (Romanello, 2021). This evidence concerns the gene OPA1 and sarcopenia.